Xulin Hong
Overview
Explore the profile of Xulin Hong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
27
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fu J, Zhang N, Xu C, Zhao M, Wu S, Xu S, et al.
ACS Nano
. 2024 Dec;
19(1):451-469.
PMID: 39723585
Synthetic vascular grafts are promising conduits for small caliber arteries. However, due to restenosis caused by intimal hyperplasia, they cannot keep long patency in vivo. In this work, through single...
2.
Ye Y, Chen Y, Jiang H, Zeng J, Wang X, Yang Y, et al.
Heart Rhythm
. 2024 Nov;
PMID: 39551121
Background: Patients with an indication for a cardiovascular implantable electronic device (CIED) are complicated with special cardiomyopathy or other unspecified cardiac abnormalities and may need endomyocardial biopsy (EMB). However, EMB...
3.
Xiang G, Cao G, Gao M, Hu T, He W, Gu C, et al.
Front Cardiovasc Med
. 2024 Nov;
11:1382374.
PMID: 39507387
Objective: This study aims to explore the association between risk stratification and total occlusion (TO) of the culprit artery and multivessel disease (MVD) in patients with non-ST-segment-elevation myocardial infarction (NSTEMI)...
4.
Yu F, Chen S, Tian L, Hong X, Wang B, Wu L, et al.
Cardiovasc Diagn Ther
. 2024 Sep;
14(4):478-488.
PMID: 39263470
Background: Patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) predicts the interaction between an implanted device and the surrounding anatomy. In this study, we validated the predictive value of...
5.
Xue Z, Ye M, Jiang H, Li D, Hong X, Chen Z, et al.
Clin Cardiol
. 2024 Jun;
47(6):e24301.
PMID: 38895772
Background: Statins are lipid-lowering drugs with favorable anti-inflammatory effects. This study aimed to explore different statin-based lipid-lowering strategies to reduce high-sensitivity C-reactive protein (hs-CRP). Hypothesis: The hypothesis is that different...
6.
Jiang H, Yang S, Chen Z, Li D, Shan Y, Tao Y, et al.
Heliyon
. 2023 Dec;
9(11):e22284.
PMID: 38045122
Background: Glasgow prognostic score (GPS) is a reliable scoring system reflecting both nutritional and inflammatory factors. The association of inflammation and nutrition with contrast-associated acute kidney injury (CA-AKI) has been...
7.
Zhao J, Wu S, Zhang M, Hong X, Zhao M, Xu S, et al.
Acta Biomater
. 2023 Nov;
173:247-260.
PMID: 37939818
Intimal hyperplasia is a common lesion that can be observed in diverse vascular diseases. Drug-eluting stents and drug-coated balloons, which can release anti-proliferative agents to inhibit smooth muscle cell (SMC)...
8.
Li D, Chen Z, Shan Y, Hu T, Hong X, Zhu J, et al.
Ecotoxicol Environ Saf
. 2023 Aug;
263:115346.
PMID: 37579588
Aldehydes are recognized environmental toxicants that may affect lipid metabolism. For instance, acrolein has been found to increase serum triglyceride (TG) levels exclusively. However, it remains unclear whether other aldehydes...
9.
Li D, Xu T, Xie D, Wang M, Sun S, Wang M, et al.
J Med Internet Res
. 2023 Apr;
25:e44939.
PMID: 37043273
Background: Elevated low-density lipoprotein cholesterol (LDL-C) is an established risk factor for atherosclerotic cardiovascular disease (ASCVD). However, low adherence to medication and lifestyle management has limited the benefits of lowering...
10.
Liu X, He W, Hong X, Li D, Chen Z, Wang Y, et al.
BMC Cardiovasc Disord
. 2022 Nov;
22(1):484.
PMID: 36371146
Objective: Vulnerable plaques with fibrous cap thickness (FCT) of ≤65 μm are prone to rupture and/or thrombosis. However, plaques with FCT > 65 μm cause acute myocardial infarction and even...